Boston Scientific acquired Xlumena in April, 2015. "We believe the acquisition of Xlumena and their minimally-invasive products combined with the Boston Scientific broad product portfolio demonstrates our commitment to advancing the field of interventional EUS therapeutics," said David Pierce, senior vice president and president, Endoscopy, Boston Scientific.
Investors 2
Funding Rounds 2
| Date | Series | Amount | Investors |
| 03.12.2013 | Series C | $25M | - |
| 29.04.2011 | Series B | $7M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 03.12.2013 | Xlumena Closes $25M in Series C Financing | Xlumena, a Mountain View, CA-based developer of advanced endoscopic devices, closed $25m in Series C... | finsmes.co... |
| 03.12.2013 | Xlumena wraps up $25M Series C round | Xlumena said it closed a $25 million Series C round it plans to use to expand its commercial footpri... | massdevice... |
| 03.12.2013 | Xlumena Closes $25M in Series C Financing |
MOUNTAIN VIEW, CA, Leader in the development of advanced endoscopic devices, today announced the c... | vcnewsdail... |
| 02.05.2011 | $7M for XLumena | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Mountain View, CA-based medical de... | xconomy.co... |
| 29.04.2011 | Xlumena Closes $7M Series B Financing | Xlumena, a Mountain View, California-based provider of innovative technology for the interventional ... | finsmes.co... |
| 09.06.2008 | XLumena raises $6.15M for endoscopic devices | XLumena, a Mountain View, Calif. maker of endosurgical devices, has raised $6.15 million for a new l... | venturebea... |
Reviews 0
